Our study elucidates EGCG’s inhibitory action on the overexpressed YAP-1/TEAD/CTGF axis in OSI-resistant clones, synergistically displaying anti-cancer activity by re-sensitising cells to OSI. Here, CCN2 is linked to cancer.